Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Androgens increase cervical cancer risk and affect its development.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Hirsutism in women is often caused by hormonal imbalances and can be managed with treatments targeting the underlying cause.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Future acne treatments should aggressively target inflammation to prevent scarring.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

RUM-loaded SLN shows promise for treating acne and hair loss topically.